7-APBT

7-APBT
Clinical data
Drug class	Serotonin–norepinephrine–dopamine releasing agent
Identifiers
	IUPAC name 1-(1-benzothiophen-7-yl)propan-2-amine;
PubChem CID	81148228;
ChemSpider	36641702;
Chemical and physical data
Formula	C11H13NS
Molar mass	191.29 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(CC1=CC=CC2=C1SC=C2)N;
	InChI InChI=1S/C11H13NS/c1-8(12)7-10-4-2-3-9-5-6-13-11(9)10/h2-6,8H,7,12H2,1H3; Key:WQPFTMBQNOUDIL-UHFFFAOYSA-N;

7-APBT is a monoamine releasing agent (MRA) of the amphetamine and benzothiophene families. It acts specifically as a fairly well-balanced serotonin–norepinephrine–dopamine releasing agent (SNDRA), with EC₅₀Tooltip half-maximal effective concentration values of 36.9 nM for serotonin, 28.5 nM for norepinephrine, and 16.8 nM for dopamine in rat brain synaptosomes. 7-APBT was first described in the scientific literature by 2020.